Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Charles River Laboratories International, Inc. CRL

Healthcare  —  Diagnostics & Research
292.84 (1.60) (0.54%) as of 25 Sep
Market cap
$14.1B
P/E
0.0×
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Charles River Laboratories International, Inc. (CRL) P/B ratio

As of 25 September 2026, Charles River Laboratories International, Inc. (CRL) trades at a P/B ratio of 4.9×. Over the past ten years it has ranged from 1.6× (April 2025) to 9.9× (September 2021); the current reading is higher than 69% of that period. That is above the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 3.1× 14.01%
FY2024 2.7× (17.87%)
FY2023 3.3× (10.51%)
FY2022 3.7× (50.12%)
FY2021 7.5× 27.69%
FY2020 5.8× 28.60%
FY2019 4.5× 10.54%
FY2018 4.1× (18.03%)
FY2017 5.0× 16.98%
FY2016 4.3× (15.39%)

Quarterly

Period P/B ratio Change
Jun 2026 3.8× 33.53%
Mar 2026 2.9× (8.11%)
Dec 2025 3.1× 38.14%
Sep 2025 2.3× 1.72%
42 more quarters

Against its own ten years

Low 1.6× High 9.9×
Ten-year median 4.6×
Current reading's percentile 69

P/B ratio against peers

Company P/B ratio
GH Guardant Health, Inc. compare n/m
ICLR ICON PLC compare 1.4×
RVTY Revvity Inc. compare 2.3×
QGEN QIAGEN N.V. compare 2.7×
LH Labcorp Holdings Inc. compare 2.9×
DGX Quest Diagnostics Incorporated compare 3.4×
CRL Charles River Laboratories International, Inc. 4.9×
TWST Twist Bioscience Corporation compare 25.7×
MEDP Medpace Holdings, Inc. compare 40.2×
Diagnostics & Research industry median 3.1×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on CRL